Selective cannabinoid receptor 2 modulators: a patent review 2009 – present

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.5, 2012-05, pp. : 495-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CXCR2 modulators: a patent review (2009 – 2013)

By Dwyer Michael P Yu Younong

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 519-534

Informa Healthcare

Access to resources Recommend Favorite

mGluR2 positive allosteric modulators: a patent review (2009 – present)

By Trabanco Andrés A Cid José María

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 629-647

Informa Healthcare

Access to resources Recommend Favorite

Sigma receptor modulators: a patent review

By Collina Simona Gaggeri Raffaella Marra Annamaria Bassi Andrea Negrinotti Sara Negri Francesca Rossi Daniela

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 597-613

Informa Healthcare

Access to resources Recommend Favorite

AMPA receptor positive allosteric modulators: a patent review

By Pirotte Bernard Francotte Pierre Goffin Eric de Tullio Pascal

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 615-628

Informa Healthcare

Access to resources Recommend Favorite

Hedgehog pathway inhibitors: a patent review (2009 – present)

By Hadden Matthew Kyle

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite